Sudden Cardiac Death and Syncope

Sudden cardiac death is unexpected death from a cardiac cause occurring within a short time of symptom onset, most often driven by a ventricular tachyarrhythmia. Syncope — transient loss of consciousness from a brief drop in cerebral perfusion — overlaps with this topic because some causes of syncope, particularly arrhythmic ones, mark increased risk of sudden death. This entry summarizes their mechanisms, the distinction between benign and high-risk syncope, and the framework for sudden-death prevention as a reference topic.

Definition

Sudden cardiac death is natural death due to cardiac causes, heralded by abrupt loss of consciousness within an hour of symptom onset in a person with or without known heart disease; syncope is a transient, self-limited loss of consciousness caused by global cerebral hypoperfusion, with rapid onset and spontaneous complete recovery.

Scope

The entry covers the definition and mechanisms of sudden cardiac death, the classification of syncope (reflex, orthostatic, and cardiac), the clinical features that separate benign from potentially dangerous faints, and the conceptual basis for risk stratification and implantable cardioverter-defibrillator therapy. It is descriptive and educational and does not provide individualized diagnosis or treatment.

Key concepts

• Sudden cardiac arrest and its rhythms (VT/VF)
• Reflex (vasovagal) syncope
• Orthostatic syncope
• Cardiac (arrhythmic and structural) syncope
• Risk stratification for sudden death
• Primary versus secondary prevention
• Implantable cardioverter-defibrillator (ICD)

Mechanisms

Most sudden cardiac deaths result from a ventricular tachyarrhythmia — ventricular tachycardia degenerating into ventricular fibrillation — that abolishes effective cardiac output; bradyarrhythmic and mechanical (e.g., pump failure or catastrophic structural) causes account for the remainder. Syncope shares the final pathway of transient global cerebral hypoperfusion but reaches it by several routes: reflex syncope from inappropriate autonomic vasodilation and bradycardia, orthostatic syncope from failure to maintain blood pressure on standing, and cardiac syncope from arrhythmias or structural obstruction. The clinical concern is that cardiac syncope, unlike reflex syncope, can be a warning sign on the same continuum as sudden cardiac death (Brignole et al., 2018; Zeppenfeld et al., 2022).

Clinical relevance

Distinguishing benign reflex syncope from syncope of cardiac origin is a central clinical judgement because the latter signals elevated risk of sudden death, and sudden-death prevention through risk stratification and device therapy is a major aim of cardiology. This entry describes the concepts and evidence base for educational reference and is not a basis for individual diagnosis or treatment.

Epidemiology

Sudden cardiac death is a leading mode of cardiovascular mortality, with coronary artery disease the most common underlying substrate in adults; a smaller share occurs in younger people with inherited channelopathies or cardiomyopathies. Syncope is very common in the general population and is usually reflex-mediated and benign, but cardiac causes carry a worse prognosis.

Evidence & guidelines

The ESC ventricular-arrhythmia and sudden-death guideline (Zeppenfeld et al., 2022) and syncope guideline (Brignole et al., 2018) provide the contemporary framework. Landmark trials established implantable cardioverter-defibrillators in prevention: AVID (1997) showed benefit over antiarrhythmic drugs for secondary prevention in survivors of near-fatal ventricular arrhythmias, and SCD-HeFT (Bardy et al., 2005) supported defibrillators for primary prevention in selected heart-failure patients.

History

The recognition that most sudden cardiac deaths are arrhythmic, together with the advent of external defibrillation and cardiopulmonary resuscitation in the mid-twentieth century, founded the field of resuscitation. The implantable cardioverter-defibrillator, introduced clinically in the 1980s and validated by subsequent randomized trials, shifted the emphasis from treating arrest to preventing it in identified high-risk groups.

Seminal works

• zeppenfeld-2022
• bardy-2005
• avid-1997

Frequently asked questions

Is fainting a sign of sudden cardiac death risk?

Most faints are benign reflex (vasovagal) events, but syncope caused by an arrhythmia or structural heart disease can signal elevated risk; the circumstances, warning symptoms, and underlying heart status are what distinguish low- from high-risk syncope.

What rhythm usually causes sudden cardiac death?

The most common immediate mechanism is a ventricular tachyarrhythmia — ventricular tachycardia deteriorating into ventricular fibrillation — which stops effective pumping and causes cardiac arrest.